SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-050031
Filing Date
2021-08-05
Accepted
2021-08-05 17:43:06
Documents
2
Period of Report
2021-07-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10860
2 POA DOCUMENT poa.txt EX-24.3_1002450 3757
  Complete submission text file 0001209191-21-050031.txt   16045
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Issuer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address AERIE PHARMACEUTICALS, INC. 4301 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703
Business Address
Staten Christopher (Reporting) CIK: 0001875988 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36152 | Film No.: 211149795